Can GM detection be used as a surrogate marker for early (preemptive) therapy ?
Evaluation of a surrogate marker: validity and efficiency - Qu - 2013 - Statistics in Medicine - Wiley Online Library
MRI as a surrogate marker for clinical outcomes in multiple sclerosis | Personalized Management of Multiple Sclerosis
Surrogate Markers of Vision* | Download Table
Reticulocytosis as a Surrogate Marker of Recent Pf Malaria Infection: Association with Clinical, Parasitological and Haematological outcomes: Okoth, Patrick: 9783845437156: Amazon.com: Books
Pulsatile energy consumption as a surrogate marker for vascular afterload improves with time post transcatheter aortic valve replacement in patients with aortic stenosis | Hypertension Research
Surrogate Markers and its role in the Drug Development Process - ppt video online download
Cardiac Allograft Hypertrophy: A New Target for Therapy, a Surrogate Marker for Survival? - American Journal of Transplantation
Example 1: Continuous Surrogate Marker • OptimalSurrogate
Surrogate markers are not 'one-size-fits-all' | Cleveland Clinic Journal of Medicine
Defining vitamin D deficiency, using surrogate markers – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
Noninvasive Testing and Surrogate Markers in Invasive Fungal Diseases
REBEL Cast Episode 1: Clinically Important Biphasic Anaphylaxis & Total Lymphocyte Count as a Surrogate Marker for CD4 - REBEL EM - Emergency Medicine Blog
Statistical evaluation of surrogate markers: Validity, efficiency, and sensitivity - Yongming Qu, 2013
PPT - Surrogate Markers and its role in the Drug Development Process PowerPoint Presentation - ID:533855
Surrogate marker evaluation when data are small, large, or very large (Geert Molenberghs)
Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age | SpringerLink
Statistical evaluation of surrogate markers: Validity, efficiency, and sensitivity
What Do We Know About Surrogate Markers and Disease Outcomes? (Slides with Transcript)
2 Relationship between a surrogate marker and true outcome, adjusted... | Download Scientific Diagram
![PDF] Surrogate outcome markers in research and clinical practice | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5ae9f320037de4f081b4772e3245508f1d8bc6b3/3-Figure1-1.png "PDF] Surrogate outcome markers in research and clinical practice | Semantic Scholar")
PDF] Surrogate outcome markers in research and clinical practice | Semantic Scholar
surrogate markers - List of Frontiers' open access articles
The use of surrogate end points in cardiovascular disease and diabetes - The British Journal of Cardiology
Table I from Surrogate markers in HIV disease. | Semantic Scholar
Copeptin, a surrogate marker for vasopressin, is associated with chronic kidney disease progression in patients with diabetes mellitus (ZODIAC-33) - Media Centre | EASD
UNDERSTANDING SCIENCE: SURROGATE MARKERS | Evidence Based Training
